Novavax

• NCT06485752

  Phase 2/3, Withdrawn, 0 people, 3 Jul 2024

• NCT05519839

  Phase 2, Completed, 1,579 people, 29 Aug 2022

• NCT03658629

  Phase 2, Terminated, 1,375 people, 5 Sept 2018

• Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

  Consulting or advice, Grants or research support, 15 Aug 2026

• Neighborhood Disadvantage and Dementia Risk Among Older Patients With Kidney Failure: Differences by Race/Ethnicity and Urbanicity

  Consulting or advice, Fees or honoraria, 20 Jul 2026

• Immunofitness in the elderly: The role of vaccination in promoting healthy aging

  Fees or honoraria, Grants or research support, 10 Feb 2026

• Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule

  Consulting or advice, Fees or honoraria, 24 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org